Cost · checked August 2026
$116/mo
No commitment, and no cheaper rung: this is what the site publishes.
| Plan | Per month | Charged today |
|---|---|---|
| Compounded GLP-1 Semaglutide, per 28-day supply · advertised | $116 | $116 |
$116 is the only semaglutide figure on maximustribe.com that carries a unit, and the unit is not a month: "Starting at $116 /28-day supply" on the weight-loss page. Thirteen 28-day supplies fill a 364-day year, so $116 a supply is $1,508 a year rather than the $1,392 that twelve payments would come to. Four other figures for the same product appear elsewhere on the site the same day — $79.99/month and $150 per month on the semaglutide page, $149.99 on the home page, and a comparison table reading "Cost: $149.99-$249.99 per month" whose range does not contain either of the two lowest. Maximus states no minimum term anywhere we read, and says "No membership fees, transparent pricing."
| Plan | Per month | Charged today |
|---|---|---|
| Compounded GLP-1 + GIP Tirzepatide, per 28-day supply | $198 | $198 |
"Starting at $198 /28-day supply" on the weight-loss page against "GLP-1 + GIP Starting at $249.99" on the home page, read the same day. Thirteen supplies a year at $198 is $2,574.
| Plan | Per month | Charged today |
|---|---|---|
| Wegovy® Tablets | $249.99 | $249.99 |
| Wegovy® Pens | $349.99 | $349.99 |
| Ozempic® | $349.99 | $349.99 |
The brand rungs are the only ones on the site quoted "/mo" rather than per supply. Foundayo™ tablets, an orforglipron product, are listed at "Starting at $199.99 /mo" and are not a semaglutide, so they are recorded in the supply row rather than here.
| Plan | Per month | Charged today |
|---|---|---|
| Zepbound® | $449.99 | $449.99 |
| Mounjaro® | $1,249.99 | $1,249.99 |
There are five numbers, and you get a different one depending on where you land. The home page picker offers "GLP-1 Starting at $149.99" and "GLP-1 + GIP Starting at $249.99". The weight-loss category page prices the same two products at "Starting at $116 /28-day supply" and "Starting at $198 /28-day supply". The semaglutide product page opens with "Available now starting at $79.99 /month" and then, in a bullet list a screen below it headed "The better way to lose weight", offers "Starting at $150 per month". And the comparison table on the weight-loss page describes compounded medication as "Cost: $149.99-$249.99 per month, out of pocket" — a range that contains neither $116 nor $79.99, both of which Maximus publishes for the same thing.
Only one of the five carries a unit, and the unit is not a month. A 28-day supply is four weeks, and thirteen of them fill a 364-day year. So $116 a supply is $1,508 a year, not the $1,392 that twelve payments implies, and the honest comparison figure against a company that bills monthly is nearer $126. Tirzepatide at $198 a supply comes to $2,574 a year.
The brand prices are quoted differently again, per month rather than per supply, and they are the only figures on the site with a real unit: Foundayo tablets $199.99, Wegovy tablets $249.99, Ozempic and Wegovy pens $349.99, Zepbound $449.99, Mounjaro $1,249.99. There is also a promotion running that tells you what the low compounded numbers are really for: "$100 OFF first month of medication for new clients purchasing 12-month plan."
We have priced the $116 as the entry number because it is the only compounded figure Maximus attaches a unit to, and nothing on the pages we read states a minimum term. We have not walked the intake, so which of the five appears at checkout is not something we can tell you yet. That walk is queued.
The rest of the review — what the service is like and who should skip it — is on the Maximus review. Prices move; this page was read August 2026, and the company's own site is the current source.
To see every plan above priced out line by line — the rate, any required membership, any published consultation fee, and what a prepay term charges today — use the real cost calculator. It reads the same ladder this page does, so the two cannot disagree.
Maximus is not a partner. We link to them from the review and earn nothing from it.
More reviews on the index; the rules behind them are on how we review, written by Kevin Turner.